The costimulatory molecule, CD28, induced and increased production of IL-2, enhancing the clonal expansion and endurance of CAR T cells that, when combined with 4-1BB/CD137, were more efficient in INF-γ production and lysis of tumor cells [13]. The gene discussed is TNFRSF9; the disease is neoplasm.